Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Morningside Technology Advisory is a global venture capital and private equity firm specializing in investments across life sciences and technology sectors. Founded in 1986 by the Chan family, it has offices in Boston (Cambridge), Shanghai, and London. The firm is recognized for its long-term outlook and commitment to social responsibility while supporting innovative science-driven startups from early through growth stages. It has invested over $1 billion to date with a focus on transformative technologies in biotech, pharma, digital health, AI, materials science, and more.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Morningside Technology Advisory.